227 related articles for article (PubMed ID: 27545749)
1. Elevated lipoprotein (a) levels are an independent risk factor for retinal vein occlusion.
Kuhli-Hattenbach C; Miesbach W; Lüchtenberg M; Kohnen T; Hattenbach LO
Acta Ophthalmol; 2017 Mar; 95(2):140-145. PubMed ID: 27545749
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of Elevated Lipoprotein (a) Levels in Patients < 60 Years of Age with Retinal Vein Occlusion].
Kuhli-Hattenbach C; Hellstern P; Miesbach W; Kohnen T; Hattenbach LO
Klin Monbl Augenheilkd; 2018 Jan; 235(1):81-86. PubMed ID: 27643601
[TBL] [Abstract][Full Text] [Related]
3. High lipoprotein (a) levels are associated with an increased risk of retinal vein occlusion.
Sofi F; Marcucci R; Fedi S; Giambene B; Sodi A; Menchini U; Gensini GF; Abbate R; Prisco D
Atherosclerosis; 2010 May; 210(1):278-81. PubMed ID: 20006334
[TBL] [Abstract][Full Text] [Related]
4. Coagulation disorders and the risk of retinal vein occlusion.
Kuhli-Hattenbach C; Scharrer I; Lüchtenberg M; Hattenbach LO
Thromb Haemost; 2010 Feb; 103(2):299-305. PubMed ID: 20126828
[TBL] [Abstract][Full Text] [Related]
5. [Selective thrombophilia screening of young patients with retinal vein occlusion].
Kuhli-Hattenbach C; Scharrer I; Lüchtenberg M; Hattenbach LO
Klin Monbl Augenheilkd; 2009 Sep; 226(9):768-73. PubMed ID: 19399710
[TBL] [Abstract][Full Text] [Related]
6. Thrombophilic and cardiovascular risk factors for retinal vein occlusion.
Bucciarelli P; Passamonti SM; Gianniello F; Artoni A; Martinelli I
Eur J Intern Med; 2017 Oct; 44():44-48. PubMed ID: 28684050
[TBL] [Abstract][Full Text] [Related]
7. Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion.
Kuhli C; Scharrer I; Koch F; Ohrloff C; Hattenbach LO
Am J Ophthalmol; 2004 Mar; 137(3):459-64. PubMed ID: 15013868
[TBL] [Abstract][Full Text] [Related]
8. [Multiple thrombophilic risk markers in patients ≺65 years of age with retinal vein occlusion].
Kuhli-Hattenbach C; Hellstern P; Miesbach W; Kohnen T; Hattenbach LO
Ophthalmologe; 2017 Dec; 114(12):1149-1154. PubMed ID: 28185002
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.
Lip PL; Blann AD; Jones AF; Lip GY
Eye (Lond); 1998; 12 ( Pt 2)():245-51. PubMed ID: 9683948
[TBL] [Abstract][Full Text] [Related]
10. The role of thrombophilia in patients with retinal vein occlusion and no systemic risk factors.
Rehak M; Krcova V; Slavik L; Fric E; Langova K; Ulehlova J; Rehak J
Can J Ophthalmol; 2010 Apr; 45(2):171-5. PubMed ID: 20379305
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors and Treatment Strategies in Patients With Retinal Vascular Occlusions.
Chapin J; Carlson K; Christos PJ; DeSancho MT
Clin Appl Thromb Hemost; 2015 Oct; 21(7):672-7. PubMed ID: 24335246
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein (a): a risk factor for retinal vascular occlusion.
Müller HM; Diekstall FF; Schmidt E; März W; Canzler H; Demeler U
Ger J Ophthalmol; 1992; 1(5):338-41. PubMed ID: 1477637
[TBL] [Abstract][Full Text] [Related]
13. Risk factors associated with retinal vein occlusion.
Martínez F; Furió E; Fabiá MJ; Pérez AV; González-Albert V; Rojo-Martínez G; Martínez-Larrad MT; Mena-Martín FJ; Soriguer F; Serrano-Ríos M; Chaves FJ; Martín-Escudero JC; Redón J; García-Fuster MJ
Int J Clin Pract; 2014 Jul; 68(7):871-81. PubMed ID: 24548738
[TBL] [Abstract][Full Text] [Related]
14. The role of coagulation disorders in patients with retinal vein occlusion.
Napal JJ; Neila S; Pérez-Montes R; Sierra I; Ruiz S; Hernández JL
QJM; 2016 Feb; 109(2):97-102. PubMed ID: 25972353
[TBL] [Abstract][Full Text] [Related]
15. [Thrombophilic and systemic risk factors in patients with retinal vein occlusion].
Kuhli-Hattenbach C; Miesbach W; Scharrer I; Hattenbach LO
Ophthalmologe; 2011 Feb; 108(2):104-10. PubMed ID: 21287178
[TBL] [Abstract][Full Text] [Related]
16. Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels.
Gori AM; Marcucci R; Fatini C; Gensini F; Sticchi E; Sodi A; Cappelli S; Menchini U; Gensini GF; Abbate R; Prisco D
Thromb Haemost; 2004 Jul; 92(1):54-60. PubMed ID: 15213845
[TBL] [Abstract][Full Text] [Related]
17. Risk factors, antithrombotic treatment and outcome in retinal vein occlusion: an age-related prospective cohort study.
Sartori MT; Barbar S; Donà A; Piermarocchi S; Pilotto E; Saggiorato G; Prandoni P
Eur J Haematol; 2013 May; 90(5):426-33. PubMed ID: 23461717
[TBL] [Abstract][Full Text] [Related]
18. Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age.
Arsène S; Delahousse B; Regina S; Le Lez ML; Pisella PJ; Gruel Y
Thromb Haemost; 2005 Jul; 94(1):101-6. PubMed ID: 16113792
[TBL] [Abstract][Full Text] [Related]
19. Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion.
Glueck CJ; Wang P; Bell H; Rangaraj V; Goldenberg N
Clin Appl Thromb Hemost; 2005 Oct; 11(4):375-89. PubMed ID: 16244763
[TBL] [Abstract][Full Text] [Related]
20. Is elevated level of soluble endothelial protein C receptor a new risk factor for retinal vein occlusion?
Gumus K; Kadayifcilar S; Eldem B; Saracbasi O; Ozcebe O; Dundar S; Kirazli S
Clin Exp Ophthalmol; 2006; 34(4):305-11. PubMed ID: 16764648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
